Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin

Nature Structural and Molecular Biology

Volumn 11, Issue 12, 2004, Pages 1173-1178

  Giddings, Kara S ^a   Zhao, Ji ^b   Sims, Peter J ^b   Tweten, Rodney K ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIOCIN; CD59 ANTIGEN; CHOLESTEROL; INTERMEDILYSIN PROTEIN, STREPTOCOCCUS INTERMEDIUS; TRYPSIN;

ANIMAL; ARTICLE; BINDING SITE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYME SPECIFICITY; ERYTHROCYTE; GLYCOSYLATION; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; RABBIT;

ANIMALS; ANTIGENS, CD59; BACTERIAL PROTEINS; BACTERIOCINS; BINDING SITES; CELL LINE; CHOLESTEROL; ERYTHROCYTES; GLYCOSYLATION; HUMANS; MICE; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RABBITS; SUBSTRATE SPECIFICITY; TRYPSIN;

EID: 16544370492     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb862     Document Type: Article

References (40)

1. Boulnois, G.J. Pneumococcal proteins and the pathogenesis of disease caused by £ Streptococcus pneumoniae. J. Gen. Microbiol. 138, 249-259 (1992).
2. Bricker, A.L., Cywes, C., Ashbaugh, C.D. & Wessels, M.R. NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci. Mol. Microbiol. 44, 257-269 (2002).
3. Sierig, G., Cywes, C., Wessels, M.R. & Ashbaugh, C.D. Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group A streptococci. Infect. Immun. 71, 446-455 (2003).
4. Portnoy, D., Jacks, P.S. & Hinrichs, D. The role of hemolysin for intracellular growth of Listeria monocytogenes. J. Exp. Med. 167, 1459-1471 (1988).
5. Billington, S.J., Jost, B.H., Cuevas, W.A., Bright, K.R. & Songer, J.G. The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family. J. Bacteriol. 179, 6100-6106 (1997).
6. Nagamune, H. et al. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect. Immun. 64, 3093-3100 (1996).
7. Nagamune, H. et al. Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius. J. Clin. Microbiol. 38, 220-226 (2000).
8. Olofsson, A., Hebert, H. & Thelestam, M. The projection structure of perfringolysin-O (ClostridiumperfringensT-toxin). FEBS Lett. 319, 125-127 (1993).
9. Shatursky, O. et al. The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell 99, 293-299 (1999).
10. Shepard, L.A. et al. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an a-helical to p-sheet transition identified by fluorescence spectroscopy. Biochemistry 37, 14563-14574 (1998).
11. Alouf, J.E. Introduction to the family of the structurally related cholesterol-binding cytolysins ('sulfhydryl-activated toxins'). In Bacterial Toxins: A Comprehensive Sourcebook (eds. Alouf, J. & Freer, J.) 443-456 (Academic Press, London, 1999).
12. Ohno-Iwashita, Y., Iwamoto, M., Ando, S., Mitsui, K. & Iwashita, S. A modified 0-toxin produced by limited proteolysis and methylation: a probe for the functional study of membrane cholesterol. Biochim. Biophys. Acta 1023, 441-448 (1990).
13. Geoffroy, C. & Alouf, J.E. Interaction of alveolysin A sulfhydryl-activated bacterial cyto- lytic toxin with thiol group reagents and cholesterol. Toxicon 20, 239-241 (1982).
14. Prigent, D. & Alouf, J.E. Interaction of streptolysin O with sterols. Biochem. Biophys. Acta. 433, 422-428 (1976).
15. Jacobs, T. et al. Listeriolysin O: cholesterol inhibits cytolysis but not binding to cellular membranes. Mol. Microbiol. 28, 1081-1089 (1998).
16. Giddings, K.S., Johnson, A.E. & Tweten, R.K. Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins. Proc. Natl. Acad. Sci. USA 100, 11315-11320 (2003).
17. Rollins, S.A. & Sims, P.J. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol. 144, 3478-3483 (1990).
18. Rollins, S.A., Zhao, J., Ninomiya, H. & Sims, P.J. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J. Immunol. 146, 2345-2351 (1991).
19. Chang, C.P., Husler, T., Zhao, J., Wiedmer, T. & Sims, P.J. Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59. J. Biol. Chem. 269, 26424-26430 (1994).
20. Lockert, D.H. et al. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59. J. Biol. Chem. 270, 19723-19728 (1995).
21. Gordon, V.M. et al. Clostridium septicum a-toxin uses glycosylphosphatidylinositol- anchored protein receptors. J. Biol. Chem. 274, 27274-27280 (1999).
22. Rudd, P.M. et al. The glycosylation of the complement regulatory protein, human erythrocyte CD59. J. Biol. Chem. 272, 7229-7244 (1997).
23. Petranka, J. et al. Structure-function relationships of the complement regulatory protein, CD59. Blood Cells Mol. Dis. 22, 281-296 (1996).
24. Ninomiya, H. et al. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J. Biol. Chem. 267, 8404-8410 (1992).
25. Ninomiya, H. & Sims, P.J. The human complement regulatory protein CD59 binds to the a-chain of C8 and to the 'b' domain of C9. J. Biol. Chem. 267, 13675-13680 (1992).
26. Zhang, H.F. et al. Identification of the individual residues that determine human CD59 species selective activity. J. Biol. Chem. 274, 10969-10974 (1999).
27. Zhao, X.J., Zhao, J., Zhou, Q. & Sims, P.J. Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59. J. Biol. Chem. 273, 10665-10671 (1998).
28. Shimada, Y., Maruya, M., Iwashita, S. & Ohno-Iwashita, Y. The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur. J. Biochem. 269, 6195-6203 (2002).
29. Weis, S. & Palmer, M. Streptolysin O: the C-terminal, tryptophan-rich domain carries functional sites for both membrane binding and self-interaction but not for stable oligomerization. Biochim. Biophys. Acta 1510, 292-299 (2001).
30. Fleming, T.J., O'Huigin, C. & Malek, T.R. Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to a-bungarotoxin and other neurotoxins. J. Immunol. 150, 5379-5390 (1993).
31. Fletcher, C.M., Harrison, R.A., Lachmann, P.J. & Neuhaus, D. Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure 2, 185-199 (1994).
32. Nagamune, H. et al. Intermedilysin. A cytolytic toxin specific for human cells of a Streptococcus intermedius isolated from human liver abscess. Adv. Exp. Med. Biol. 418, 773-775 (1997).
33. Whiley, R.A., Beighton, D., Winstanley, T.G., Fraser, H.Y. & Hardie, J.M. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J. Clin. Microbiol. 30, 243-244 (1992).
34. Macey, M.G., Whiley, R.A., Miller, L. & Nagamune, H. Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius. Infect. Immun. 69, 6102-6109 (2001).
35. Gordon, D.L., Papazaharoudakis, H., Sadlon, T.A., Arellano, A. & Okada, N. Upregulation of human neutrophil CD59, a regulator of the membrane attack complex of complement, following cell activation. Immunol. Cell Biol. 72, 222-229 (1994).
36. Rother, R.P., Zhao, J., Zhou, Q. & Sims, P.J. Elimination of potential sites of glycosyl- ation fails to abrogate complement regulatory function of cell surface CD59. J. Biol. Chem. 271, 23842-23845 (1996).
37. Melton, J.A., Parker, M.W., Rossjohn, J., Buckley, J.T. & Tweten, R.K. The identification and structure of the membrane-spanning domain of the Clostridium septicum a-toxin. J. Biol. Chem. 279, 14315-14322 (2004).
38. Laemmli, U.K. Cleavage of structural proteins during he assembly of the head of bacteriophage T4. Nature 227, 680-685 (1970).
39. Hotze, E.M. et al. Arresting pore formation of a cholesterol-dependent cytolysin by disulfide trapping synchronizes the insertion of the transmembrane p-sheet from a prepore intermediate. J. Biol. Chem. 276, 8261-8268 (2001).
40. Bodian, D.L., Davis, S.J., Morgan, B.P. & Rushmere, N.K. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J. Exp. Med. 185, 507-516 (1997).